268 related articles for article (PubMed ID: 29885825)
1. Long-term single-center experience of defibrillator therapy in children and adolescents.
Frommeyer G; Feder S; Bettin M; Debus V; Köbe J; Reinke F; Uebing A; Eckardt L; Kehl HG
Int J Cardiol; 2018 Nov; 271():105-108. PubMed ID: 29885825
[TBL] [Abstract][Full Text] [Related]
2. High incidence of appropriate and inappropriate ICD therapies in children and adolescents with implantable cardioverter defibrillator.
Korte T; Köditz H; Niehaus M; Paul T; Tebbenjohanns J
Pacing Clin Electrophysiol; 2004 Jul; 27(7):924-32. PubMed ID: 15271011
[TBL] [Abstract][Full Text] [Related]
3. Low Prevalence of Inappropriate Shocks in Patients With Inherited Arrhythmia Syndromes With the Subcutaneous Implantable Defibrillator Single Center Experience and Long-Term Follow-Up.
Rudic B; Tülümen E; Berlin V; Röger S; Stach K; Liebe V; El-Battrawy I; Dösch C; Papavassiliu T; Akin I; Borggrefe M; Kuschyk J
J Am Heart Assoc; 2017 Oct; 6(10):. PubMed ID: 29042423
[TBL] [Abstract][Full Text] [Related]
4. Long-Term Experience With the Subcutaneous Implantable Cardioverter-Defibrillator in Teenagers and Young Adults.
Bettin M; Larbig R; Rath B; Fischer A; Frommeyer G; Reinke F; Köbe J; Eckardt L
JACC Clin Electrophysiol; 2017 Dec; 3(13):1499-1506. PubMed ID: 29759830
[TBL] [Abstract][Full Text] [Related]
5. Performance of the entirely subcutaneous ICD in borderline indications.
Willy K; Reinke F; Bögeholz N; Köbe J; Eckardt L; Frommeyer G
Clin Res Cardiol; 2020 Jun; 109(6):694-699. PubMed ID: 31586219
[TBL] [Abstract][Full Text] [Related]
6. The entirely subcutaneous implantable cardioverter-defibrillator: initial clinical experience in a large Dutch cohort.
Olde Nordkamp LR; Dabiri Abkenari L; Boersma LV; Maass AH; de Groot JR; van Oostrom AJ; Theuns DA; Jordaens LJ; Wilde AA; Knops RE
J Am Coll Cardiol; 2012 Nov; 60(19):1933-9. PubMed ID: 23062537
[TBL] [Abstract][Full Text] [Related]
7. Implantable cardioverter defibrillator therapy in paediatric practice: a single-centre UK experience with focus on subcutaneous defibrillation.
Griksaitis MJ; Rosengarten JA; Gnanapragasam JP; Haw MP; Morgan JM
Europace; 2013 Apr; 15(4):523-30. PubMed ID: 23333943
[TBL] [Abstract][Full Text] [Related]
8. Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia.
Roses-Noguer F; Jarman JW; Clague JR; Till J
Heart Rhythm; 2014 Jan; 11(1):58-66. PubMed ID: 24120999
[TBL] [Abstract][Full Text] [Related]
9. Transvenous and non-transvenous implantable cardioverter-defibrillators in children, adolescents, and adults with congenital heart disease: who is at risk for appropriate and inappropriate shocks?
Krause U; Müller MJ; Wilberg Y; Pietzka M; Backhoff D; Ruschewski W; Paul T
Europace; 2019 Jan; 21(1):106-113. PubMed ID: 30339209
[TBL] [Abstract][Full Text] [Related]
10. Primary Results From the Understanding Outcomes With the S-ICD in Primary Prevention Patients With Low Ejection Fraction (UNTOUCHED) Trial.
Gold MR; Lambiase PD; El-Chami MF; Knops RE; Aasbo JD; Bongiorni MG; Russo AM; Deharo JC; Burke MC; Dinerman J; Barr CS; Shaik N; Carter N; Stoltz T; Stein KM; Brisben AJ; Boersma LVA;
Circulation; 2021 Jan; 143(1):7-17. PubMed ID: 33073614
[TBL] [Abstract][Full Text] [Related]
11. Specific indications and clinical outcome in patients with subcutaneous implantable cardioverter-defibrillator (ICD) - A nationwide multicentre registry.
Sponder M; Khazen C; Dichtl W; Fiedler L; Mörtl D; Teubl A; Steinwender C; Martinek M; Nürnberg M; Dalos D; Kastner J; Schukro C
Eur J Intern Med; 2018 Feb; 48():64-68. PubMed ID: 28978409
[TBL] [Abstract][Full Text] [Related]
12. Comparison of transvenous vs subcutaneous defibrillator therapy in patients with cardiac arrhythmia syndromes and genetic cardiomyopathies.
Kuschyk J; Müller-Leisse J; Duncker D; Tülümen E; Fastenrath F; Fastner C; Kruska M; Akin I; Liebe V; Borggrefe M; Veltmann C; Rudic B
Int J Cardiol; 2021 Jan; 323():100-105. PubMed ID: 32871189
[TBL] [Abstract][Full Text] [Related]
13. Outcome after implantation of a cardioverter-defibrillator in patients with Brugada syndrome: a multicenter study-part 2.
Sacher F; Probst V; Maury P; Babuty D; Mansourati J; Komatsu Y; Marquie C; Rosa A; Diallo A; Cassagneau R; Loizeau C; Martins R; Field ME; Derval N; Miyazaki S; Denis A; Nogami A; Ritter P; Gourraud JB; Ploux S; Rollin A; Zemmoura A; Lamaison D; Bordachar P; Pierre B; Jaïs P; Pasquié JL; Hocini M; Legal F; Defaye P; Boveda S; Iesaka Y; Mabo P; Haïssaguerre M
Circulation; 2013 Oct; 128(16):1739-47. PubMed ID: 23995538
[TBL] [Abstract][Full Text] [Related]
14. Safety and Efficacy of Subcutaneous Cardioverter Defibrillator in Patients at High Risk of Sudden Cardiac Death - Primary Japanese Experience.
Sasaki S; Tomita H; Tsurugi T; Ishida Y; Shoji Y; Nishizaki K; Kinjo T; Endo T; Nishizaki F; Hanada K; Sasaki K; Horiuchi D; Kimura M; Higuma T; Okamatsu H; Tanaka Y; Koyama J; Okumura K
Circ J; 2018 May; 82(6):1546-1551. PubMed ID: 29643282
[TBL] [Abstract][Full Text] [Related]
15. Effectiveness of subcutaneous implantable cardioverter-defibrillators and determinants of inappropriate shock delivery.
Mesquita J; Cavaco D; Ferreira A; Lopes N; Santos PG; Carvalho MS; Haas A; Costa F; Carmo P; Morgado F; Adragão P; Mendes M
Int J Cardiol; 2017 Apr; 232():176-180. PubMed ID: 28082086
[TBL] [Abstract][Full Text] [Related]
16. Intensive recreational athletes in the prospective multinational ICD Sports Safety Registry: Results from the European cohort.
Heidbuchel H; Willems R; Jordaens L; Olshansky B; Carre F; Lozano IF; Wilhelm M; Müssigbrodt A; Huybrechts W; Morgan J; Anfinsen OG; Prior D; Mont L; Mairesse GH; Boveda S; Duru F; Kautzner J; Viskin S; Geelen P; Cygankiewicz I; Hoffmann E; Vandenberghe K; Cannom D; Lampert R
Eur J Prev Cardiol; 2019 May; 26(7):764-775. PubMed ID: 30813818
[TBL] [Abstract][Full Text] [Related]
17. Subcutaneous implantable cardioverter defibrillator in children and adolescents: results from the S-ICD "Monaldi care" registry.
Sarubbi B; Colonna D; Correra A; Romeo E; D'Alto M; Palladino MT; Virno S; D'Onofrio A; Russo MG
J Interv Card Electrophysiol; 2022 Mar; 63(2):283-293. PubMed ID: 33709295
[TBL] [Abstract][Full Text] [Related]
18. Comparison between atrial fibrillation-triggered implantable cardioverter-defibrillator (ICD) shocks and inappropriate shocks caused by lead failure: different impact on prognosis in clinical practice.
Kleemann T; Hochadel M; Strauss M; Skarlos A; Seidl K; Zahn R
J Cardiovasc Electrophysiol; 2012 Jul; 23(7):735-40. PubMed ID: 22313314
[TBL] [Abstract][Full Text] [Related]
19. Long-time "real-life" performance of the subcutaneous ICD in patients with electrical heart disease or idiopathic ventricular fibrillation.
Frommeyer G; Dechering DG; Kochhäuser S; Bettin M; Köbe J; Eckardt L; Reinke F
J Interv Card Electrophysiol; 2016 Nov; 47(2):185-188. PubMed ID: 27217031
[TBL] [Abstract][Full Text] [Related]
20. Survival after shock therapy in implantable cardioverter-defibrillator and cardiac resynchronization therapy-defibrillator recipients according to rhythm shocked. The ALTITUDE survival by rhythm study.
Powell BD; Saxon LA; Boehmer JP; Day JD; Gilliam FR; Heidenreich PA; Jones PW; Rousseau MJ; Hayes DL
J Am Coll Cardiol; 2013 Oct; 62(18):1674-1679. PubMed ID: 23810882
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]